Black Hole Sign under Anticoagulant Therapy: A Retrospective Comparison of Warfarin and Direct Oral Anticoagulants

References

1. 1.↵
   1. Chan NC,
   2. Paikin JS,
   3. Hirsh J, et al

   . New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions. Thromb Haemost 2014;111:798–807 doi:10.1160/TH13-11-0918 pmid:24553904

   CrossRefPubMed
2. 2.↵
   1. Dowlatshahi D,
   2. Butcher KS,
   3. Asdaghi N

   ; Canadian PCC Registry (CanPro) Investigators, et al. Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal. Stroke 2012;43:1812–17 doi:10.1161/STROKEAHA.112.652065 pmid:22556194

   Abstract/FREE Full Text
3. 3.↵
   1. Kurogi R,
   2. Nishimura K,
   3. Nakai M

   ; J-ASPECT Study Collaborators, et al. Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin. Neurology 2018;90:e1143–e1149 doi:10.1212/WNL.0000000000005207 pmid:29490916

   CrossRefPubMed
4. 4.↵
   1. Brouwers HB,
   2. Greenberg SM

   . Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis 2013;35:195–201 doi:10.1159/000346599 pmid:23466430

   CrossRefPubMed
5. 5.↵
   1. Li Q,
   2. Zhang G,
   3. Xiong X, et al

   . Black hole sign: novel imaging marker that predicts hematoma growth in patients with intracerebral hemorrhage. Stroke 2016;47:1777–81 doi:10.1161/STROKEAHA.116.013186 pmid:27174523

   Abstract/FREE Full Text
6. 6.↵
   1. Li Q,
   2. Yang WS,
   3. Chen SL, et al

   . Black hole sign predicts poor outcome in patients with intracerebral hemorrhage. Cerebrovasc Dis 2018;45:48–53 doi:10.1159/000486163 pmid:29402824

   CrossRefPubMed
7. 7.↵
   1. He GN,
   2. Guo HZ,
   3. Han X, et al

   . Comparison of CT black hole sign and other CT features in predicting hematoma expansion in patients with ICH. J Neurol 2018;265:1883–90 doi:10.1007/s00415-018-8932-6 pmid:29948249

   CrossRefPubMed
8. 8.↵
   1. Kothari RU,
   2. Brott T,
   3. Broderick JP, et al

   . The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304–05 doi:10.1161/01.str.27.8.1304 pmid:8711791

   Abstract/FREE Full Text
9. 9.↵
   1. Dowlatshahi D,
   2. Demchuk AM,
   3. Flaherty ML

   ; VISTA Collaboration, et al. Defining hematoma expansion in intracerebral hemorrhage: relationship with patient outcomes. Neurology 2011;76:1238–44 doi:10.1212/WNL.0b013e3182143317 pmid:21346218

   Abstract/FREE Full Text
10. 10.↵
    1. Wilson D,
    2. Charidimou A,
    3. Shakeshaft C

    ; CROMIS-2 Collaborators, et al. Volume and functional outcome of intracerebral hemorrhage according to oral anticoagulant type. Neurology 2016;86:360–66 doi:10.1212/WNL.0000000000002310 pmid:26718576

    Abstract/FREE Full Text
11. 11.↵
    1. Hagii J,
    2. Tomita H,
    3. Metoki N, et al

    . Characteristics of intracerebral hemorrhage during rivaroxaban treatment: comparison with those during warfarin. Stroke 2014;45:2805–07 doi:10.1161/STROKEAHA.114.006661 pmid:25082810

    Abstract/FREE Full Text
12. 12.↵
    1. von der Brelie C,
    2. Doukas A,
    3. Naumann R, et al

    . Clinical and radiological course of intracerebral haemorrhage associated with the new non-vitamin K anticoagulants. Acta Neurochir (Wien) 2017;159:101–09 doi:10.1007/s00701-016-3026-7 pmid:27873051

    CrossRefPubMed
13. 13.↵
    1. Demchuk AM,
    2. Dowlatshahi D,
    3. Rodriguez-Luna D

    ; PREDICT/Sunnybrook ICH CTA Study Group, et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012;11:307–14 doi:10.1016/S1474-4422(12)70038-8 pmid:22405630

    CrossRefPubMed
14. 14.↵
    1. Fisher CM

    . Pathological observations in hypertensive cerebral hemorrhage. J Neuropathol Exp Neurol 1971;30:536–50 doi:10.1097/00005072-197107000-00015 pmid:4105427

    CrossRefPubMed
15. 15.↵
    1. Barras CD,
    2. Tress BM,
    3. Christensen S

    ; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators, et al. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke 2009;40:1325–31 doi:10.1161/STROKEAHA.108.536888 pmid:19286590

    Abstract/FREE Full Text
16. 16.↵
    1. Takeda R,
    2. Ogura T,
    3. Ooigawa H, et al

    . A practical prediction model for early hematoma expansion in spontaneous deep ganglionic intracerebral hemorrhage. Clin Neurol Neurosurg 2013;115:1028–31 doi:10.1016/j.clineuro.2012.10.016 pmid:23245855

    CrossRefPubMed
17. 17.↵
    1. Brouwers HB,
    2. Chang Y,
    3. Falcone GJ, et al

    . Predicting hematoma expansion after primary intracerebral hemorrhage. JAMA Neurol 2014;71:158–64 doi:10.1001/jamaneurol.2013.5433 pmid:24366060

    CrossRefPubMed
18. 18.↵
    1. Romero JM,
    2. Heit JJ,
    3. Delgado Almandoz JE, et al

    . Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage. Emerg Radiology 2012;19:195–202 doi:10.1007/s10140-012-1020-9 pmid:22271362

    CrossRefPubMed
19. 19.↵
    1. Chen Y,
    2. Tian L,
    3. Wang L, et al

    . Black hole sign on noncontrast computed tomography in predicting hematoma expansion in patients with intracerebral hemorrhage: a meta-analysis. Curr Med Imaging 2020;16:878–86 doi:10.2174/1573405615666190903155738 pmid:33059557

    CrossRefPubMed
20. 20.↵
    1. Li Q,
    2. Zhang G,
    3. Huang YJ, et al

    . Blend sign on computed tomography: novel and reliable predictor for early hematoma growth in patients with intracerebral hemorrhage. Stroke 2015;46:2119–23 doi:10.1161/STROKEAHA.115.009185 pmid:26089330

    Abstract/FREE Full Text
21. 21.↵
    1. Li Q,
    2. Liu QJ,
    3. Yang WS, et al

    . Island sign: an imaging predictor for early hematoma expansion and poor outcome in patients with intracerebral hemorrhage. Stroke 2017;48:3019–25 doi:10.1161/STROKEAHA.117.017985 pmid:29018128

    Abstract/FREE Full Text